PATENTS – patent for formulations of liraglutide – validity of extension of term of patent – where application for extension must concern a patent which discloses a ‘pharmaceutical substance per se’ under s 70 of the Patents Act 1990 – whether ‘pharmaceutical substance’ includes formulations of active ingredients and excipients – whether excipients required to be for distinct therapeutic use
Related Federal Court patent cases
-
The NOCO Company v Brown and Watson International Pty Ltd [2025] FCA 887
The NOCO Company v Brown and Watson International Pty Ltd [2025] FCA 887
-
CPC Patent Technologies Pty Ltd v Apple Pty Limited [2025] FCA 489
PATENTS – patents for secure access systems – claim construction – infringement – validity PATENTS – construction of the asserted claims – construction of seven contested integers PATENTS – infringement – where the impugned devices incorporate biometric security systems utilising fingerprint and face recognition – factual contest regarding operation of the impugned devices – no…
-
Miele & Cie KG v Bruckbauer [2025] FCA 537
PATENTS – application to amend claims of a patent application under s 105 of the Patents Act 1990 (Cth) due to typographical error – correction of obvious mistake PATENTS – infringement – standard patent for a hob with a recess for a device for downwardly removing cooking vapours through suction – claim construction PATENTS –…
